STOCK TITAN

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Precipio (NASDAQ: PRPO), a specialty cancer diagnostics company, has scheduled its Q4 and year-end 2024 shareholder update conference call for March 31st, 2025 at 5:00 PM EST. The call will provide updates on all of the company's core businesses.

Shareholders can access the call through:

  • Dial-in: 844-695-5519 (US) or 1-412-902-6760 (International)
  • Pre-registration link: https://dpregister.com/sreg/10197585/fea81a2627

Investors can submit questions in advance via email to investors@precipiodx.com. A replay will be available approximately 24 hours after the call on Precipio's investor relations website.

Precipio (NASDAQ: PRPO), un'azienda specializzata nella diagnostica oncologica, ha programmato la sua conferenza telefonica per l'aggiornamento degli azionisti del quarto trimestre e dell'anno 2024 per il 31 marzo 2025 alle 17:00 EST. La chiamata fornirà aggiornamenti su tutte le attività principali dell'azienda.

Gli azionisti possono accedere alla chiamata tramite:

  • Numero da chiamare: 844-695-5519 (USA) o 1-412-902-6760 (Internazionale)
  • Link per la pre-registrazione: https://dpregister.com/sreg/10197585/fea81a2627

Gli investitori possono inviare domande in anticipo via email a investors@precipiodx.com. Una registrazione sarà disponibile circa 24 ore dopo la chiamata sul sito web delle relazioni con gli investitori di Precipio.

Precipio (NASDAQ: PRPO), una empresa especializada en diagnósticos de cáncer, ha programado su conferencia telefónica de actualización para accionistas del cuarto trimestre y del año 2024 para el 31 de marzo de 2025 a las 5:00 PM EST. La llamada proporcionará actualizaciones sobre todos los negocios principales de la empresa.

Los accionistas pueden acceder a la llamada a través de:

  • Llamada: 844-695-5519 (EE. UU.) o 1-412-902-6760 (Internacional)
  • Enlace de preinscripción: https://dpregister.com/sreg/10197585/fea81a2627

Los inversores pueden enviar preguntas con anticipación por correo electrónico a investors@precipiodx.com. Una grabación estará disponible aproximadamente 24 horas después de la llamada en el sitio web de relaciones con inversores de Precipio.

프레시피오 (NASDAQ: PRPO), 전문 암 진단 회사가 2024년 4분기 및 연말 주주 업데이트 컨퍼런스 콜을 2025년 3월 31일 오후 5시 EST로 예정했습니다. 이 통화에서는 회사의 주요 사업에 대한 업데이트가 제공됩니다.

주주들은 다음을 통해 통화에 접속할 수 있습니다:

  • 전화 번호: 844-695-5519 (미국) 또는 1-412-902-6760 (국제)
  • 사전 등록 링크: https://dpregister.com/sreg/10197585/fea81a2627

투자자들은 미리 질문을 이메일로 investors@precipiodx.com으로 보낼 수 있습니다. 통화 후 약 24시간 이내에 프레시피오의 투자자 관계 웹사이트에서 재생이 가능합니다.

Precipio (NASDAQ: PRPO), une entreprise spécialisée dans le diagnostic du cancer, a programmé sa conférence téléphonique de mise à jour pour les actionnaires du quatrième trimestre et de l'année 2024 pour le 31 mars 2025 à 17h00 EST. L'appel fournira des mises à jour sur toutes les activités principales de l'entreprise.

Les actionnaires peuvent accéder à l'appel via :

  • Numéro de téléphone : 844-695-5519 (États-Unis) ou 1-412-902-6760 (International)
  • Lien de pré-inscription : https://dpregister.com/sreg/10197585/fea81a2627

Les investisseurs peuvent soumettre des questions à l'avance par e-mail à investors@precipiodx.com. Un enregistrement sera disponible environ 24 heures après l'appel sur le site Web des relations avec les investisseurs de Precipio.

Precipio (NASDAQ: PRPO), ein Unternehmen für spezialisierte Krebsdiagnostik, hat seine Telefonkonferenz zur Aktualisierung der Aktionäre für das vierte Quartal und das Jahr 2024 auf den 31. März 2025 um 17:00 Uhr EST angesetzt. In der Konferenz werden Updates zu allen Kernbereichen des Unternehmens bereitgestellt.

Aktionäre können über folgende Wege auf die Konferenz zugreifen:

  • Telefonnummer: 844-695-5519 (USA) oder 1-412-902-6760 (International)
  • Link zur Voranmeldung: https://dpregister.com/sreg/10197585/fea81a2627

Investoren können im Voraus Fragen per E-Mail an investors@precipiodx.com senden. Eine Aufzeichnung wird etwa 24 Stunden nach der Konferenz auf der Investor Relations-Website von Precipio verfügbar sein.

Positive
  • None.
Negative
  • None.

Conference Call to be held on March 31st, 2025 at 5:00 PM EST

NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4 and year end 2024 corporate update call on March 31st, 2025 at 5:00 PM ET. The call will include updates on all of the company’s current core businesses.

The conference call may be accessed by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Precipio Inc. conference call. Participants may also pre-register for the conference call to https://dpregister.com/sreg/10197585/fea81a2627 and will receive a calendar invite and a direct dial-in number, bypassing the operator.

Listeners interested in submitting questions in advance should email their questions to investors@precipiodx.com and management will do its best to address those questions during the call.

A replay of the call will be available approximately 24 hours after the call and may be accessed via the Investors page on Precipio's website, https://www.precipiodx.com/investors/.

About Precipio

Precipio is a healthcare biotechnology company focused on cancer diagnostics. Our mission is to address the pervasive problem of cancer misdiagnoses by developing solutions in the form of diagnostic products and services. Our products and services deliver higher accuracy, improved laboratory workflow, and ultimately better patient outcomes, which reduce healthcare expenses. Precipio develops innovative technologies in our laboratory where we design, test, validate, and use these products clinically, improving diagnostic outcomes. Precipio then commercializes these technologies as proprietary products that serve the global laboratory community and further scales Precipio’s reach to eradicate misdiagnosis.

Availability of Other Information About Precipio

For more information, please visit the Precipio website at https://www.precipiodx.com/ or follow Precipio on X (formerly Twitter) (@PrecipioDx) and LinkedIn (Precipio) and on Facebook. Investors and others should note that we communicate with our investors and the public using our company website (https://www.precipiodx.com), including, but not limited to, company disclosures, investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference call transcripts and webcast transcripts, as well as on X and LinkedIn. The information that we post on our website or on X or LinkedIn could be deemed to be material information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website or social media shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the targets set herein and related timing.
Except for historical information, statements about future volumes, sales, growth, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, cash flows, adjusted EBITDA, plans, objectives, expectations, growth or profitability and our potential to reach financial independence are forward-looking statements based on management’s estimates, beliefs, assumptions and projections. Words such as “could,” “may,” “expects,” “anticipates,” “will,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “predicts,” and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance, are intended to identify such forward-looking statements. These forward-looking statements are only predictions based on management’s current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the important factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and our other reports filed with the U.S. Securities and Exchange Commission. Any such forward-looking statements represent management’s estimates as of the date of this press release only. While we may elect to update such forward-looking statements at some point in the future, except as required by law, we disclaim any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.



Inquiries:

investors@precipiodx.com

+1-203-787-7888 Ext. 523

FAQ

When is Precipio (PRPO) holding its Q4 and year-end 2024 earnings call?

Precipio will hold its Q4 and year-end 2024 update call on March 31st, 2025 at 5:00 PM EST.

How can investors join Precipio's (PRPO) Q4 2024 earnings call?

Investors can dial 844-695-5519 (US) or 1-412-902-6760 (international), or pre-register via the provided link to bypass the operator.

Can shareholders submit questions for Precipio's (PRPO) earnings call?

Yes, shareholders can email questions in advance to investors@precipiodx.com.

Where can I find the replay of Precipio's (PRPO) Q4 2024 earnings call?

The replay will be available approximately 24 hours after the call on Precipio's website under the Investors page.
Precipio Inc

NASDAQ:PRPO

PRPO Rankings

PRPO Latest News

PRPO Stock Data

7.63M
1.31M
12.6%
4.95%
0.72%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
OMAHA